ES2131468B1 - USE OF MELATONIN IN THE TREATMENT OF NEURODEGENERATIVE DISEASES. - Google Patents
USE OF MELATONIN IN THE TREATMENT OF NEURODEGENERATIVE DISEASES.Info
- Publication number
- ES2131468B1 ES2131468B1 ES9701212A ES9701212A ES2131468B1 ES 2131468 B1 ES2131468 B1 ES 2131468B1 ES 9701212 A ES9701212 A ES 9701212A ES 9701212 A ES9701212 A ES 9701212A ES 2131468 B1 ES2131468 B1 ES 2131468B1
- Authority
- ES
- Spain
- Prior art keywords
- melatonin
- treatment
- neurodegenerative diseases
- hormone
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
Uso de la melatonina en el tratamiento de las enfermedades neurodegenerativas. La invención se refiere al uso de la melatonina en la preparación de composiciones útiles para prevenir y para evitar el progreso de los síntomas en las enfermedades neurodegenerativas. También se refiere al uso de esta hormona en combinación con otros antioxidantes o con otros inhibidores de la proliferación celular para el tratamiento y prevención de dichas alteraciones. El uso de esta hormona tiene las ventajas sobre otros medicamentos utilizados en dichos tratamientos de que es un agente antioxidante e inhibidor de la proliferación celular endógeno que no posee efectos secundarios, atraviesa fácilmente la barrera hematoencefálica, y ejerce sus efectos en todos los compartimentos celulares.Use of melatonin in the treatment of neurodegenerative diseases. The invention relates to the use of melatonin in the preparation of compositions useful for preventing and preventing the progression of symptoms in neurodegenerative diseases. It also refers to the use of this hormone in combination with other antioxidants or with other inhibitors of cell proliferation for the treatment and prevention of said alterations. The use of this hormone has the advantages over other drugs used in such treatments in that it is an antioxidant agent and inhibitor of endogenous cell proliferation that has no side effects, easily crosses the blood-brain barrier, and exerts its effects on all cell compartments.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9701212A ES2131468B1 (en) | 1997-05-29 | 1997-05-29 | USE OF MELATONIN IN THE TREATMENT OF NEURODEGENERATIVE DISEASES. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9701212A ES2131468B1 (en) | 1997-05-29 | 1997-05-29 | USE OF MELATONIN IN THE TREATMENT OF NEURODEGENERATIVE DISEASES. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2131468A1 ES2131468A1 (en) | 1999-07-16 |
ES2131468B1 true ES2131468B1 (en) | 2000-04-01 |
Family
ID=8299558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9701212A Expired - Fee Related ES2131468B1 (en) | 1997-05-29 | 1997-05-29 | USE OF MELATONIN IN THE TREATMENT OF NEURODEGENERATIVE DISEASES. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2131468B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2209649B1 (en) * | 2002-12-09 | 2005-03-16 | Carlos Arana Molina (Titular Al 25%) | USE OF MELATONINE FOR BUCODENTAL HYGIENE FOR HUMAN AND VETERINARY USE AS AN ACTIVE PRODUCT. |
ES2213473B1 (en) * | 2002-12-31 | 2005-10-01 | Carlos Arana Molina (Titular Al 25%) | USE OF MELATONIN FOR THE OSEA REGENERATION OF HUMAN AND VETERINARY USE AS AN ACTIVE PRODUCT. |
-
1997
- 1997-05-29 ES ES9701212A patent/ES2131468B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2131468A1 (en) | 1999-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0207961A8 (en) | USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS. | |
UY26092A1 (en) | USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES | |
ES2191152T3 (en) | COMBINED THERAPY FOR THE TREATMENT OF PSYCHOSIS. | |
ES2377720T3 (en) | AGON�? STICOS ANTIBODIES EPHA2 AND METHODS OF USE OF THE SAME. | |
ES2157601T3 (en) | USE OF ANTI-MICROTUBLE AGENTS TO TREAT OR PREVENT MULTIPLE SCLEROSIS. | |
AR002007A1 (en) | A THERAPEUTIC COMPOSITION OF TOPICAL APPLICATION CONTAINING AN ANTAGONIST OF SUBSTANCE P AND USE OF SUCH ANTAGONIST FOR THE PREPARATION OF SUCH COMPOSITION TO DECREASE AND / OR ELIMINATE AN IRRITATING SIDE EFFECT OF A PRODUCT CONTAINED IN IT. | |
ES2157027T3 (en) | OXAZOLIDINONES REPLACED AND ITS USE AS ANTIBACTERIAL PHARMACOS. | |
PA8443001A1 (en) | PREVENTION OF LOSS AND RESTORATION OF THE BONE MASS BY CERTAIN PROSTAGLANDIN AGONISTS | |
GT199900147A (en) | 1, 2, 3, 4- TETRAHIDROQUINOLINAS 2-SUBSTITUTED 4-AMINO SUBSTITUTED. | |
ES2161085T3 (en) | FORMULATIONS CONTAINING OXALIPLATIN. | |
CO5160262A1 (en) | PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION | |
ECSP045520A (en) | TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS | |
PT705100E (en) | THERAPEUTIC SUBSTITUTED GUANIDINS | |
AR021370A1 (en) | STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS CONTAINING TAXOID ANTI-NEOPLASIC AGENTS | |
AR003119A1 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING VIROSIC INFECTIONS OR INHIBITING THE GROWTH OF TUMORS OR CANCERES WHICH INCLUDE A MIXTURE OF A N-CHLOROPHENYL CARBAMATE OR A N-CHLOROPHENITIC CARBAMATE AND A N- PHOSPHONOGLYCAN FOR DICHAUTIC DURATION INHIBIT THE GROWTH OF TUMORS OR CANCERS | |
AR002987A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OCCURRING VIRAL INFECTIONS OR TUMORS, COMPOSITION OF UNITARY DOSE THAT INCLUDES IT AND USE FOR SUCH TREATMENT | |
BR0213181A (en) | Cox-2 inhibitor combinations | |
ES2163795T3 (en) | PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND INFECTIONS BY PAPILOMAVIRUS. | |
BR0307017A (en) | fast acting sedative hypnotic agents for anesthesia and sedation | |
PT1032414E (en) | COMBINATION OF AN INHIBITOR OF THE ANGIOTENSIN CONVERSATION ENZYME AND A DIURETIC FOR THE TREATMENT OF MICROCIRCULATORY DISTURBACTIONS | |
UY27203A1 (en) | USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION | |
ES2188995T3 (en) | USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS. | |
AR015945A1 (en) | AUTOFOBIC HAIR SPRAY COMPOSITIONS | |
ES2164447T3 (en) | BONE RESORTION INHIBITION PROCEDURE. | |
AR043660A1 (en) | THE TREATMENT OF ALZHEIMER'S DISEASE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19990716 Kind code of ref document: A1 Effective date: 19990716 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20170905 |